IRM vs MAZE · P/E 136, rev $6.15B vs $525.3M cap
Iron Mountain Incorporated (IRM) versus Maze Therapeutics, Inc. Common Stock (MAZE) — a side-by-side from cached financials, not a winner call.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Latest reported IRM revenue for 2024-12-31 was $6.15B. Net income was $183.7M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Latest reported MAZE revenue for 2025-06-30 was $0. Net income was -$66.5M. Revenue was down 100.0% from 2024-09-30 to 2025-06-30. MAZE currently screens at market cap $525.3M.
IRM currently screens at market cap $37.09B and trailing P/E 135.5. MAZE currently screens at market cap $525.3M.
Not investment advice. Open the IRM and MAZE stock pages for the full models.
Not investment advice.